NCT Number: NCT07269262
This pilot randomized controlled trial evaluates the feasibility, acceptability, and accessibility of SUPPORT-T, a digitally delivered palliative care intervention for patients with Progressive Pulmonary Fibrosis (PPF) and their caregivers. The intervention includes a 9-week digital application guided by a nurse interventionist and quarterly virtual support groups over one year. Participants will be recruited from rural South Carolina and urban New York City. The study compares SUPPORT-T to Enhanced Usual Care and aims to inform a future multi-site trial.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Charleston, South Carolina, 29425, United States
Location status: Recruiting
Kathleen Lindell, PhD, RN, ATSF, FAAN
CONTACT
Kathleen Lindell, PhD, RN, ATSF, FAAN
PRINCIPAL_INVESTIGATOR
Mary Chris Pittman, BA
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Caregiver Inclusion Criteria:
Exclusion criteria
-
SUPPORT-T will be delivered biweekly at TeleHealth Visits 1-4 via a secure interface via MUSC telehealth platform. The nurse interventionist will receive results from the REDCap survey after each TH visit and contact the patient biweekly after each TH visit using the MUSC Telehealth and/or Health platform. The nurse interventionist will be available for any questions and communicate with the participants via bi-directional texts (SC will maintain a log of those texts)
Time frame: 10 months
Feasibility outcomes include number of participants recruited weekly, number of participants who declined, and number of participants who did not meet eligibility requirements, data collection procedures, and participant responses. Feasibility data will inform future studies on approaches for recruitment and retention, study procedures, and timing and participant capacity to complete surveys/interviews.
Time frame: 10 months
Feasibility outcomes include number of participants recruited weekly, number of participants who declined, and number of participants who did not meet eligibility requirements, data collection procedures, and participant responses. Feasibility data will inform future studies on approaches for recruitment and retention, study procedures, and timing and participant capacity to complete surveys/interviews.
Contact information is provided by the study sponsor or research team.
Medical University of South Carolina
Other
Feasibility and Acceptability of a Mobile Application "SUPPORT-T" to Increase Equitable Access to Palliative Care in Patients With Progressive Pulmonary Fibrosis (PPF) and Their Caregivers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05943535
Interstitial Lung Disease, Lung Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT06855329
Interstitial Lung Disease, Lung Diseases
Worcester, Massachusetts, United States
View Trial DetailsNCT04905693
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Birmingham, Alabama, United States
View Trial DetailsNCT06329401
Alveolitis, Extrinsic Allergic, Fibrosis
Birmingham, Alabama, United States
View Trial Details